查詢結果分析
來源資料
相關文獻
- Infective Endocarditis with Septic Shock in a Rheumatoid Arthritis Patient Being Treated with Etanercept
- 豬博德氏菌、巴氏桿菌、放線桿菌、丹毒絲狀菌及假性狂犬病不活化五合一混合疫苗之研製與田間應用試驗
- Rheumatoid Arthritis with Porphyria and Bilateral Upper-Lobe Opacities--An Unusual Presentation of Bronchiolitis Obliterans-Organizing Pneumonia
- 豬博德氏菌、巴氏桿菌、放線桿菌、大腸桿菌、沙氏桿菌及假性狂犬病不活化混合菌(疫)苗之研製及田間應用試驗
- Sepsis and Septic Shock Following Pneumonia in Pregnancy may Cause Adverse Pregnant Outcome
- 豬博德氏菌、巴氏桿菌、胸膜肺炎放線桿菌及大腸桿菌多價混合菌苗對小豬移行抗體之消長及免疫適期之建立
- 草綠色鏈球菌菌血症之臨床意義
- Bronchiolitis Obliterans-Organizing Pneumonia--A Rare Presentation of Rheumatoid Arthritis with Lung Involvement: A Case Report and Literature Review
- Secondary Sjogren's Syndrome Complicated with Multiple Pulmonary Cysts and Lymphocytic Interstitial Pneumonitis--A Case Report and Literature Review
- 一位敗血症病童接受體外循環維生系統治療之加護護理經驗
頁籤選單縮合
題名 | Infective Endocarditis with Septic Shock in a Rheumatoid Arthritis Patient Being Treated with Etanercept=類風濕性關節炎使用Etanercept的病人併發感染性心內膜炎及敗血性休克 |
---|---|
作者姓名(中文) | 蔡明儒; 連啟惇; 蔡忠榮; 吳正欽; 顏正賢; | 書刊名 | 胸腔醫學 |
卷期 | 27:5 2012.10[民101.10] |
頁次 | 頁282-286 |
分類號 | 415.695 |
關鍵詞 | 感染性心內膜炎; 類風濕性關節炎; 敗血症; 肺炎; Infective endocarditis; Rheumatoid arthritis; Etanercept; Sepsis; Pneumonia; |
語文 | 英文(English) |
中文摘要 | 類風濕性關節炎是一種慢性多關節發炎性疾病,其真正的形成原因目前仍不甚清楚。生物製劑已被廣泛地應用在類風濕性關節炎的治療。其中,etanercept是一種常被使用的生物製劑,它是由第二型腫瘤壞死因子接受器與免疫球蛋白G1(IgG1)結合而成。這類生物製劑被認為有可能會增加嚴重感染的風險。在此,我們報告一個使用etanercept治療類風濕性關節炎病人所發生的感染性心內膜炎併發敗血性休克。經過適當的復甦與抗生素治療,此病患恢復良好;其主動脈瓣上的贅生物也在治療後消失不見。據我們了解,這是醫學文獻上初次報告感染性心內膜炎併發敗血性休克發生在使用etanercept治療類風濕性關節炎病人。我們提出這個報告以提醒臨床醫師在處方這類生物製劑時須特別謹慎。 |
英文摘要 | Rheumatoid arthritis (RA) is a chronic inflammatory polyarticular disorder of unknown cause. Nowadays, biologic agents are widely used to treat RA. Etanercept, a tumor necrosis factor (TNF) type II receptor fused to IgG1, is one of the most commonly used biologic agents. Increased risk of serious infections is recognized as a potential side effect, of which reactivation of tuberculosis is particularly notable. We report the case of a patient with infective endocarditis complicated with septic shock, who had been receiving etanercept for his refractory RA. Through appropriate resuscitation and antibiotic treatment, the patient had a good recovery with resolution of the vegetation on the aortic valve. To the best of our knowledge, this is the first report in the medical literature describing a RA patient taking etanercept complicated with infective endocarditis. Physicians should be cautious when considering the use of biologic agents. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。